|
EDITOR IN CHIEF
Alberto Corsini
Editorial Board
Maurizio Averna
Michel Farnier
Meral Kayikcioglu
Luis Masana
Andrea Poli
Evgeny V. Shlyakhto
Margus Viigimaa
Editorial office
Olga Brigida
Elisa Gardini
Angela Pirillo
Roberto Zecca
Journal Manager
Danilo Ruggeri
ISSN
2785-7115
Secretariat
Via Balzaretti 7
20133 - Milano
Invia email
Attribution-NonCommercial-NoDerivatives
4.0 International
(CC BY-NC-ND 4.0)
|
The European Atherosclerosis Journal is a new international, peer-reviewed, fully open access, four-monthly journal covering all topics within atherosclerosis and cardiovascular disease areas. The Journal aims to publish high quality research and follows strict rules to assess originality and best practices for authorship and disclosure of potential conflicts of interest.
The European Atherosclerosis Journal is the international official journal of SITeCS (Italian Society for Experimental and Clinical Therapeutics).
European Atherosclerosis Journal is an international journal that publishes papers in the field of atherosclerosis and cardiovascular disease, from basic research to clinical and translational studies. Meta-analysis and systematic reviews will also be accepted. Papers will be considered for publication based on originality and contribution to the field. The journal will consider for publication original articles (experimental and clinical), review articles, methodology papers, editorials, letters to the Editor, viewpoints, congress/conference reports.
European Atherosclerosis Journal is published by SITeCS under a Creative Commons Attribution Non-Commercial No Derivatives license (CC BY-NC-ND)
© The Author(s). Published by SITeCS
Copyright retained by the author but commercial rights transferred to the publisher. For commercial re-use please contact the Editorial Office.
The Editorial Board invites you to submit a paper.  European Atherosclerosis Journal - Guidelines for Authors in pdf format
Current issue:
• EAJ Vol 3, No 3 (2024)
In this issue:
• |
Original article
LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients at high and very-high cardiovascular risk: A simulation study in the Italian cohort of the SANTORINI study
Marcello Arca, Angela Pirillo, Rosanna Gambacurta, Christian Becker, Françoise Diamand, Kausik K Ray, Alberico L. Catapano
EAJ 2024;3:57-66
Atherosclerotic cardiovascular disease and measurement of lipoprotein(a) levels in Italy
Elena Olmastroni, Manuela Casula, Sining Xie, Alberico L. Catapano
EAJ 2024;3:67-72
|
• |
Review
Antihypertensive and renal protection effects of lercanidipine and lercanidipine/enalapril
Nicola Ferri, Alberto Corsini, Roberto Pontremoli
EAJ 2024;3:73-80
|
• |
Short Communication
SMASH: An initiative for equitable access to precision medicine for rare or severe lipid disorders
Miriam Larouche, Marianne Abifadel, Alberico L. Catapano, Marina Cuchel, Raul D. Santos, Frederick J. Raal, Daniel Gaudet
EAJ 2024;3:81-86
|
• |
Congress - conference report
The XVIII National Congress of the Società Italiana di Terapia Clinica e Sperimentale (SITeCS)
Sining Xie, Manuela Casula, Federica Galimberti, Alberto Corsini, Alberico L. Catapano
EAJ 2024;3:87-89
|
• |
Selected abstract
Investigating plasma and brain cholesterol esterification in patients with amyotrophic lateral sclerosis
Chiara Comi, Chiara Pavanello, Matteo Farè, Francesca Gerardi, Federica Cerri, Lucio Tremolizzo, Laura Calabresi
EAJ 2024;3:90
Neutrophil behavior during the metabolic adaptations to short term high fat feeding
Anna Parolini, Annalisa Moregola, Lorenzo Da Dalt, Alessia Rubino, Ottavia Terenghi, Giuseppe Danilo Norata, Andrea Baragetti
EAJ 2024;3:90
Modulation of mitochondrial dynamism in Kupffer cells impacts systemic metabolism
Francesca Fantini, Lorenzo Da Dalt, Annalisa Moregola, Giovanni Battista Vingiani, Ottavia Terenghi, Elena Donetti, Silvia Roda, Patrizia Uboldi, Monika Svecla, Jasmine Nour, Rossella Bellini, Fabrizia Bonacina, Giuseppe Danilo Norata
EAJ 2024;3:91
Efficacy of oral semaglutide on cardiovascular risk in patients with type 2 diabetes mellitus: A real-life study
Francesca Nicolì, Giulia Ongis, Provvidenza Villari, Giancarla Meregalli, Antonio Maria Labate
EAJ 2024;3:91
A retrospective cohort study on factors influencing the initiation of lipid-lowering therapy in hospitalized patients following a cardio-cerebrovascular event
Elena Olmastroni, Stefano Scotti, Federica Galimberti, Asiiat Alieva, Sining Xie, Alberico L. Catapano, Manuela Casula
EAJ 2024;3:92
Angiopoietin-like 3 (ANGPTL3) deficiency alters metabolic substrates utilization and reprograms hepatic metabolism
Ottavia Terenghi , Lorenzo Da Dalt, Francesca Fantini, Giovanni Battista Vingiani, Annalisa Moregola, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe Danilo Norata
EAJ 2024;3:92
|
•
|
Corrigendum
Corrigendum: LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients at high and very-high cardiovascular risk: A simulation study in the Italian cohort of the SANTORINI study
EAJ 2024;3:93
|
|
Archives 2024
• EAJ Vol 3, No 2 (2024)
• EAJ Vol 3, No 1 (2024)
Archives 2023
• EAJ Vol 2, No 3 (2023)
• EAJ Vol 2, No 2 (2023)
• EAJ Vol 2, No 1 (2023)
Archives 2022
• EAJ Vol 1, No 3 (2022)
• EAJ Vol 1, No 2 (2022)
• EAJ Vol 1, No 1 (2022)
|
19° Congresso Nazionale
